Nektar Therapeutics

NasdaqCM:NKTR Stock Report

Market Cap: US$238.7m

Nektar Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:NKTR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Feb 24SellUS$6,130Jonathan ZalevskyIndividual9,014US$0.68
20 Feb 24SellUS$13,622Howard RobinIndividual20,033US$0.68
20 Feb 24SellUS$5,172Mark WilsonIndividual7,606US$0.68
17 Nov 23SellUS$3,518Mark WilsonIndividual7,179US$0.49
17 Nov 23SellUS$4,727Jonathan ZalevskyIndividual9,646US$0.49
17 Nov 23SellUS$9,740Howard RobinIndividual19,877US$0.49
18 Sep 23SellUS$3,008Jeffrey AjerIndividual4,359US$0.69
18 Sep 23SellUS$3,008Myriam J. McAdamsIndividual4,359US$0.69
16 Aug 23SellUS$7,568Jonathan ZalevskyIndividual9,703US$0.78
16 Aug 23SellUS$15,598Howard RobinIndividual19,998US$0.78
16 Aug 23SellUS$5,632Mark WilsonIndividual7,221US$0.78
16 May 23SellUS$5,431Mark WilsonIndividual7,543US$0.72
16 May 23SellUS$7,050Jonathan ZalevskyIndividual9,791US$0.72
16 May 23SellUS$14,660Howard RobinIndividual20,361US$0.72

Insider Trading Volume

Insider Buying: NKTR insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of NKTR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,2840.0056%
Individual Insiders2,100,5051.14%
VC/PE Firms18,400,00010%
General Public58,174,72631.7%
Institutions104,932,30257.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 60.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10%
Deep Track Capital, LP
18,400,000US$23.9m0%0.92%
6.56%
The Vanguard Group, Inc.
12,042,873US$15.7m-0.15%no data
4.26%
Acadian Asset Management LLC
7,818,804US$10.2m2.52%0.03%
3.81%
PRIMECAP Management Company
7,001,747US$9.1m-2.73%0.01%
3.32%
BlackRock, Inc.
6,104,217US$7.9m-20.6%no data
3.25%
Monaco Asset Management S.A.M.
5,973,387US$7.8m24.2%3.22%
3.06%
Citadel Advisors LLC
5,625,000US$7.3m0%0.01%
2.9%
Renaissance Technologies LLC
5,325,475US$6.9m51.9%0.01%
2.86%
GSA Capital Partners LLP
5,255,790US$6.8m185%0.69%
2.23%
D. E. Shaw & Co., L.P.
4,098,844US$5.3m-33.1%0.01%
1.92%
Alyeska Investment Group, L.P.
3,519,272US$4.6m164%0.03%
1.85%
Jacobs Levy Equity Management Inc
3,404,165US$4.4m-30.6%0.02%
1.67%
Two Sigma Advisers, LP
3,069,542US$4.0m-18.1%0.01%
1.63%
TCG Crossover Management, LLC
3,000,000US$3.9m0%0.4%
1.34%
Assenagon Asset Management S.A.
2,466,267US$3.2m-13%0.01%
1.3%
Marshall Wace LLP
2,386,241US$3.1m-18.7%0.01%
1.28%
Tang Capital Management, LLC
2,348,109US$3.1m-40.4%0.39%
1.19%
Two Sigma Investments, LP
2,176,981US$2.8m-22.1%0.01%
1.11%
Geode Capital Management, LLC
2,039,614US$2.7m4.31%no data
1.05%
Lynx1 Capital Management LP
1,929,198US$2.5m9.19%0.6%
0.87%
Millennium Management LLC
1,596,149US$2.1m34.1%no data
0.78%
AQR Capital Management, LLC
1,435,549US$1.9m-60.8%no data
0.68%
UBS O'Connor LLC
1,250,742US$1.6m-9.12%0.16%
0.6%
Balyasny Asset Management L.P.
1,100,000US$1.4m-17.5%no data
0.6%
Charles Schwab Investment Management, Inc.
1,093,926US$1.4m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.